INOVIO PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 416.00 shares, a 94.90% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 8.16K shares.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 118.69K shares, a 90.94% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 416.00 shares 10-K · filed 2026-03-12 | |
| 2024-12-31 | 8.16K shares 10-K · filed 2025-03-18 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2024-03-06 | |
| 2022-12-31 | 118.69K shares 10-K · filed 2023-03-01 | |
| 2021-12-31 | 1.31M shares 10-K · filed 2022-03-01 | |
| 2020-12-31 | 2.18M shares 10-K · filed 2021-03-01 | |
| 2019-12-31 | 42.97K shares 10-K · filed 2020-03-12 | |
| 2018-12-31 | 472.76K shares 10-K · filed 2019-03-12 | |
| 2017-12-31 | 452.97K shares 10-K · filed 2018-03-14 | |
| 2016-12-31 | 631.07K shares 10-K · filed 2017-03-15 | |
| 2015-12-31 | 125.26K shares 10-K · filed 2016-03-14 | |
| 2014-12-31 | 294.44K shares 10-K · filed 2015-03-16 | |
| 2013-12-31 | 1.93M shares 10-K · filed 2014-03-17 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-17 | |
| 2011-12-31 | 68.31K shares 10-K · filed 2014-03-17 | |
| 2010-12-31 | 297.46K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |